# Kerry Gairy

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kerry-gairy/

## Facts

| Field | Value |
| --- | --- |
| Citations | 916 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 15 |
| i10-index | 17 |
| Last Known Institution | Health Economics and Outcomes Research (United Kingdom) |
| OpenAlex ID | https://openalex.org/A5066451028 |
| ORCID iD | 0000-0001-8591-1396 |
| Works | 41 |

## Researcher papers

Showing 12 of 15.

- [Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression](https://scholariq.org/papers/systemic-lupus-erythematosus-lupus-nephritis-and-end-stage-renal-disease-a/)
- [10 Years of belimumab experience: What have we learnt?](https://scholariq.org/papers/10-years-of-belimumab-experience-what-have-we-learnt/)
- [A Meta-Analysis of Osteoporotic Fracture Risk with Medication Nonadherence](https://scholariq.org/papers/a-meta-analysis-of-osteoporotic-fracture-risk-with-medication-nonadherence/)
- [Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial](https://scholariq.org/papers/cost-effectiveness-of-ranibizumab-in-treatment-of-diabetic-macular-oedema-dme/)
- [Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review](https://scholariq.org/papers/efficacy-and-safety-of-widely-used-treatments-for-macular-oedema-secondary-to/)
- [Real-World Effectiveness of Belimumab in the Treatment of Systemic Lupus Erythematosus: Pooled Analysis of Multi-Country Data from the OBSErve Studies](https://scholariq.org/papers/real-world-effectiveness-of-belimumab-in-the-treatment-of-systemic-lupus/)
- [The Economic Burden of Lupus Nephritis: A Systematic Literature Review](https://scholariq.org/papers/the-economic-burden-of-lupus-nephritis-a-systematic-literature-review/)
- [Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD](https://scholariq.org/papers/chronic-airways-assessment-test-psychometric-properties-in-patients-with-asthma/)
- [Cost of illness associated with Niemann-Pick disease type C in the UK](https://scholariq.org/papers/cost-of-illness-associated-with-niemann-pick-disease-type-c-in-the-uk/)
- [The Impact of CT Colonography for Colorectal Cancer Screening on the UK NHS](https://scholariq.org/papers/the-impact-of-ct-colonography-for-colorectal-cancer-screening-on-the-uk-nhs/)
- [Health-related quality of life, fatigue and health utilities in lupus nephritis: A systematic literature review](https://scholariq.org/papers/health-related-quality-of-life-fatigue-and-health-utilities-in-lupus-nephritis-a/)
- [Real-World Burden of Immunosuppressant-Treated Lupus Nephritis: A German Claims Database Analysis](https://scholariq.org/papers/real-world-burden-of-immunosuppressant-treated-lupus-nephritis-a-german-claims/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)

## Researcher university

- [Health Economics and Outcomes Research (United Kingdom)](https://scholariq.org/institutions/health-economics-and-outcomes-research-united-kingdom/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.